ArticleScientific reports2025
Diversity and enzymatic activity of Polish beehive products microbiota, and characterization of a novel β-galactosidase from Paenibacillus sp. 8.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Microbial enzymes are widely used in many industries, and beehive products are an abundant source of microorganisms. In this study, bacteria, yeasts, and filamentous fungi were isolated from Polish honey and bee bread samples and were investigated as enzyme producers. The best producers of glycoside hydrolases were Paenibacillus spp., whereas Micrococcus spp. showed high proteolytic and lipolytic activity. The β-galactosidase-encoding bgaP gene from Paenibacillus sp. 8 was cloned and expressed in Escherichia coli. BgaP, a hexameric protein with a molecular mass of 466 kDa, was optimally active at pH 6.6-7.0 and 40 °C, and maintained 18% of its maximum activity at 10 °C. β-Galactosidase was strongly inhibited by galactose, moderately by glucose, and slightly by fructose; therefore, it hydrolyzed lactulose much more efficiently than lactose. The efficiency of lactose digestion by BgaP was increased to almost 80% by the L-arabinose isomerase-catalyzed bioconversion of galactose to tagatose. These features make BgaP β-galactosidase a potential candidate for application in lactulose detection and in the production of health-promoting sweeteners. Furthermore, the cell-free extract of Paenibacillus sp. 8 hydrolyzed lactose in milk and synthesized galactooligosaccharides at 10 °C, indicating the presence of β-galactosidase other than BgaP in bacterial cells, justifying further research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.